Panda Nidhi Bidyut, Bharadwaj Neerja, Kapoor Puneet, Chari Pramila, Panda Naresh K
Department of Anesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
J Otolaryngol. 2004 Apr;33(2):88-92. doi: 10.2310/7070.2004.02091.
To determine the efficacy of a combination of ondansetron and dexamethasone in preventing postoperative nausea and vomiting after middle ear surgery compared with ondansetron alone.
A prospective, randomized, double-blind study with prestudy power analysis performed to determine the sample size.
A tertiary teaching hospital.
One hundred patients undergoing tympanomastoidectomy under general anesthesia were included in the study. Patients in group O (n = 50) received ondansetron 4 mg and those in group OD (n = 50) received ondansetron 4 mg with dexamethasone 8 mg 30 minutes before the end of surgery. All patients were monitored for nausea score, episodes of vomiting, and rescue antiemetic requirement in 48 hours after surgery. The total number of complete responders was calculated. Patients' satisfaction at the end of the study period was also estimated.
In patients receiving combination antiemetic (group OD), the nausea score was significantly less (p < .01) at 6, 12, and 24 hours after surgery. The total incidence of vomiting was reduced from 28% in group O to 6% in group OD. Rescue antiemetic requirement was significantly less (p < .01) in group OD. The number of complete responders significantly improved in the combination group (92% vs 62%). The patients were also found to be more satisfied in this group.
Prophylaxis with a combination of ondansetron and dexamethasone decreased the incidence of nausea and vomiting after middle ear surgery to a minimum and improved patients' satisfaction significantly in the postoperative period.
比较昂丹司琼与地塞米松联合用药和单独使用昂丹司琼预防中耳手术后恶心呕吐的疗效。
一项前瞻性、随机、双盲研究,进行预研究功效分析以确定样本量。
一家三级教学医院。
100例接受全身麻醉下鼓室乳突切除术的患者纳入本研究。O组(n = 50)患者在手术结束前30分钟接受4 mg昂丹司琼,OD组(n = 50)患者在手术结束前30分钟接受4 mg昂丹司琼加8 mg地塞米松。所有患者在术后48小时监测恶心评分、呕吐发作次数及补救性止吐药的使用需求。计算完全缓解者的总数。还评估了研究期末患者的满意度。
接受联合止吐药治疗的患者(OD组)在术后6、12和24小时恶心评分显著更低(p <.01)。呕吐总发生率从O组的28%降至OD组的6%。OD组补救性止吐药的使用需求显著更少(p <.01)。联合组完全缓解者的数量显著增加(92%对62%)。该组患者也更满意。
昂丹司琼与地塞米松联合预防可将中耳手术后恶心呕吐的发生率降至最低,并在术后显著提高患者满意度。